These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 15580153

  • 1. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
    Oldfield EC.
    Rev Gastroenterol Disord; 2004; 4(4):186-95. PubMed ID: 15580153
    [Abstract] [Full Text] [Related]

  • 2. Treatment strategies for C. difficile associated diarrhea.
    Stepan C, Surawicz CM.
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [Abstract] [Full Text] [Related]

  • 3. Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea.
    Stepan C, Surawicz CM.
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):295-305. PubMed ID: 19072422
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of infections associated with Clostridium difficile].
    Szczesny A, Martirosian G.
    Wiad Lek; 2003 Dec; 56(5-6):278-82. PubMed ID: 14526488
    [Abstract] [Full Text] [Related]

  • 7. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D, Kuyumjian AG, Wynd MA, Cicogna CE.
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [Abstract] [Full Text] [Related]

  • 8. [Clostridium difficile associated diarrhea (CDAD)--hard to crack].
    Goldberg E, Bishara J.
    Harefuah; 2009 Nov; 148(11):783-7, 791. PubMed ID: 20027984
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP, Surawicz CM.
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
    Pépin J, Routhier S, Gagnon S, Brazeau I.
    Clin Infect Dis; 2006 Mar 15; 42(6):758-64. PubMed ID: 16477549
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and appropriateness of empiric metronidazole for Clostridium difficile-associated diarrhea.
    Vasa CV, Glatt AE.
    Am J Gastroenterol; 2003 Feb 15; 98(2):354-8. PubMed ID: 12591054
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea.
    Gorenek L, Dizer U, Besirbellioglu B, Eyigun CP, Hacibektasoglu A, Van Thiel DH.
    Hepatogastroenterology; 1999 Feb 15; 46(25):343-8. PubMed ID: 10228818
    [Abstract] [Full Text] [Related]

  • 18. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS, McDermott BP, Parchuri S, Cunha BA.
    Am J Med; 2006 Apr 15; 119(4):356.e7-8. PubMed ID: 16564786
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.